Summary

The global Montelukast Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Montelukast Drug Industry Forecast” looks at past sales and reviews total world Montelukast Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Montelukast Drug sales for 2025 through 2031. With Montelukast Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Drug industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablets
Oral Granules
Segmentation by Application:
Hospital
Drug Store
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Drug market?
What factors are driving Montelukast Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Drug market opportunities vary by end market size?
How does Montelukast Drug break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Montelukast Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Montelukast Drug by Country/Region, 2020, 2024 & 2031
2.2 Montelukast Drug Segment by Type
2.2.1 Tablets
2.2.2 Oral Granules
2.3 Montelukast Drug Sales by Type
2.3.1 Global Montelukast Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Montelukast Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Montelukast Drug Sale Price by Type (2020-2025)
2.4 Montelukast Drug Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 Others
2.5 Montelukast Drug Sales by Application
2.5.1 Global Montelukast Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Montelukast Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Montelukast Drug Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Montelukast Drug Breakdown Data by Company
3.1.1 Global Montelukast Drug Annual Sales by Company (2020-2025)
3.1.2 Global Montelukast Drug Sales Market Share by Company (2020-2025)
3.2 Global Montelukast Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Montelukast Drug Revenue by Company (2020-2025)
3.2.2 Global Montelukast Drug Revenue Market Share by Company (2020-2025)
3.3 Global Montelukast Drug Sale Price by Company
3.4 Key Manufacturers Montelukast Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Drug Product Location Distribution
3.4.2 Players Montelukast Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Montelukast Drug by Geographic Region
4.1 World Historic Montelukast Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Montelukast Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Montelukast Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Montelukast Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Montelukast Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Montelukast Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Montelukast Drug Sales Growth
4.4 APAC Montelukast Drug Sales Growth
4.5 Europe Montelukast Drug Sales Growth
4.6 Middle East & Africa Montelukast Drug Sales Growth
5 Americas
5.1 Americas Montelukast Drug Sales by Country
5.1.1 Americas Montelukast Drug Sales by Country (2020-2025)
5.1.2 Americas Montelukast Drug Revenue by Country (2020-2025)
5.2 Americas Montelukast Drug Sales by Type (2020-2025)
5.3 Americas Montelukast Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Drug Sales by Region
6.1.1 APAC Montelukast Drug Sales by Region (2020-2025)
6.1.2 APAC Montelukast Drug Revenue by Region (2020-2025)
6.2 APAC Montelukast Drug Sales by Type (2020-2025)
6.3 APAC Montelukast Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Drug by Country
7.1.1 Europe Montelukast Drug Sales by Country (2020-2025)
7.1.2 Europe Montelukast Drug Revenue by Country (2020-2025)
7.2 Europe Montelukast Drug Sales by Type (2020-2025)
7.3 Europe Montelukast Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Drug by Country
8.1.1 Middle East & Africa Montelukast Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Montelukast Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Montelukast Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Montelukast Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Drug
10.3 Manufacturing Process Analysis of Montelukast Drug
10.4 Industry Chain Structure of Montelukast Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Drug Distributors
11.3 Montelukast Drug Customer
12 World Forecast Review for Montelukast Drug by Geographic Region
12.1 Global Montelukast Drug Market Size Forecast by Region
12.1.1 Global Montelukast Drug Forecast by Region (2026-2031)
12.1.2 Global Montelukast Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Montelukast Drug Forecast by Type (2026-2031)
12.7 Global Montelukast Drug Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Montelukast Drug Product Portfolios and Specifications
13.1.3 Merck & Co. Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Montelukast Drug Product Portfolios and Specifications
13.2.3 Teva Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Montelukast Drug Product Portfolios and Specifications
13.3.3 Mylan Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Montelukast Drug Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
13.5 Hikma Group
13.5.1 Hikma Group Company Information
13.5.2 Hikma Group Montelukast Drug Product Portfolios and Specifications
13.5.3 Hikma Group Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hikma Group Main Business Overview
13.5.5 Hikma Group Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Montelukast Drug Product Portfolios and Specifications
13.6.3 Sandoz Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Torrent Pharmaceuticals
13.7.1 Torrent Pharmaceuticals Company Information
13.7.2 Torrent Pharmaceuticals Montelukast Drug Product Portfolios and Specifications
13.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Torrent Pharmaceuticals Main Business Overview
13.7.5 Torrent Pharmaceuticals Latest Developments
13.8 Lannett Company
13.8.1 Lannett Company Company Information
13.8.2 Lannett Company Montelukast Drug Product Portfolios and Specifications
13.8.3 Lannett Company Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lannett Company Main Business Overview
13.8.5 Lannett Company Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Montelukast Drug Product Portfolios and Specifications
13.9.3 Apotex Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Dr. Reddys Laboratories
13.10.1 Dr. Reddys Laboratories Company Information
13.10.2 Dr. Reddys Laboratories Montelukast Drug Product Portfolios and Specifications
13.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Dr. Reddys Laboratories Main Business Overview
13.10.5 Dr. Reddys Laboratories Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Montelukast Drug Product Portfolios and Specifications
13.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Accord Healthcare
13.12.1 Accord Healthcare Company Information
13.12.2 Accord Healthcare Montelukast Drug Product Portfolios and Specifications
13.12.3 Accord Healthcare Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Accord Healthcare Main Business Overview
13.12.5 Accord Healthcare Latest Developments
13.13 Hetero
13.13.1 Hetero Company Information
13.13.2 Hetero Montelukast Drug Product Portfolios and Specifications
13.13.3 Hetero Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hetero Main Business Overview
13.13.5 Hetero Latest Developments
13.14 Unimark
13.14.1 Unimark Company Information
13.14.2 Unimark Montelukast Drug Product Portfolios and Specifications
13.14.3 Unimark Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Unimark Main Business Overview
13.14.5 Unimark Latest Developments
13.15 Ajanta Pharma
13.15.1 Ajanta Pharma Company Information
13.15.2 Ajanta Pharma Montelukast Drug Product Portfolios and Specifications
13.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Ajanta Pharma Main Business Overview
13.15.5 Ajanta Pharma Latest Developments
13.16 MACLEODS
13.16.1 MACLEODS Company Information
13.16.2 MACLEODS Montelukast Drug Product Portfolios and Specifications
13.16.3 MACLEODS Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 MACLEODS Main Business Overview
13.16.5 MACLEODS Latest Developments
13.17 Jubilant Pharma
13.17.1 Jubilant Pharma Company Information
13.17.2 Jubilant Pharma Montelukast Drug Product Portfolios and Specifications
13.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Jubilant Pharma Main Business Overview
13.17.5 Jubilant Pharma Latest Developments
13.18 Unichem Laboratories
13.18.1 Unichem Laboratories Company Information
13.18.2 Unichem Laboratories Montelukast Drug Product Portfolios and Specifications
13.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Unichem Laboratories Main Business Overview
13.18.5 Unichem Laboratories Latest Developments
13.19 Amneal Pharmaceuticals
13.19.1 Amneal Pharmaceuticals Company Information
13.19.2 Amneal Pharmaceuticals Montelukast Drug Product Portfolios and Specifications
13.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Amneal Pharmaceuticals Main Business Overview
13.19.5 Amneal Pharmaceuticals Latest Developments
13.20 Shanghai Anbison Lab
13.20.1 Shanghai Anbison Lab Company Information
13.20.2 Shanghai Anbison Lab Montelukast Drug Product Portfolios and Specifications
13.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Shanghai Anbison Lab Main Business Overview
13.20.5 Shanghai Anbison Lab Latest Developments
13.21 Perrigo
13.21.1 Perrigo Company Information
13.21.2 Perrigo Montelukast Drug Product Portfolios and Specifications
13.21.3 Perrigo Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Perrigo Main Business Overview
13.21.5 Perrigo Latest Developments
13.22 Cipla
13.22.1 Cipla Company Information
13.22.2 Cipla Montelukast Drug Product Portfolios and Specifications
13.22.3 Cipla Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Cipla Main Business Overview
13.22.5 Cipla Latest Developments
13.23 CSPC Ouyi Pharmaceutical
13.23.1 CSPC Ouyi Pharmaceutical Company Information
13.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolios and Specifications
13.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 CSPC Ouyi Pharmaceutical Main Business Overview
13.23.5 CSPC Ouyi Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Montelukast Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Montelukast Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Oral Granules
Table 5. Global Montelukast Drug Sales by Type (2020-2025) & (K Units)
Table 6. Global Montelukast Drug Sales Market Share by Type (2020-2025)
Table 7. Global Montelukast Drug Revenue by Type (2020-2025) & ($ million)
Table 8. Global Montelukast Drug Revenue Market Share by Type (2020-2025)
Table 9. Global Montelukast Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Montelukast Drug Sale by Application (2020-2025) & (K Units)
Table 11. Global Montelukast Drug Sale Market Share by Application (2020-2025)
Table 12. Global Montelukast Drug Revenue by Application (2020-2025) & ($ million)
Table 13. Global Montelukast Drug Revenue Market Share by Application (2020-2025)
Table 14. Global Montelukast Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Montelukast Drug Sales by Company (2020-2025) & (K Units)
Table 16. Global Montelukast Drug Sales Market Share by Company (2020-2025)
Table 17. Global Montelukast Drug Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Montelukast Drug Revenue Market Share by Company (2020-2025)
Table 19. Global Montelukast Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Montelukast Drug Producing Area Distribution and Sales Area
Table 21. Players Montelukast Drug Products Offered
Table 22. Montelukast Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Montelukast Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Montelukast Drug Sales Market Share Geographic Region (2020-2025)
Table 27. Global Montelukast Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Montelukast Drug Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Montelukast Drug Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Montelukast Drug Sales Market Share by Country/Region (2020-2025)
Table 31. Global Montelukast Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Montelukast Drug Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 34. Americas Montelukast Drug Sales Market Share by Country (2020-2025)
Table 35. Americas Montelukast Drug Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Montelukast Drug Sales by Type (2020-2025) & (K Units)
Table 37. Americas Montelukast Drug Sales by Application (2020-2025) & (K Units)
Table 38. APAC Montelukast Drug Sales by Region (2020-2025) & (K Units)
Table 39. APAC Montelukast Drug Sales Market Share by Region (2020-2025)
Table 40. APAC Montelukast Drug Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Montelukast Drug Sales by Type (2020-2025) & (K Units)
Table 42. APAC Montelukast Drug Sales by Application (2020-2025) & (K Units)
Table 43. Europe Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 44. Europe Montelukast Drug Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Montelukast Drug Sales by Type (2020-2025) & (K Units)
Table 46. Europe Montelukast Drug Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Montelukast Drug Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Montelukast Drug Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Montelukast Drug Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Montelukast Drug
Table 52. Key Market Challenges & Risks of Montelukast Drug
Table 53. Key Industry Trends of Montelukast Drug
Table 54. Montelukast Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Montelukast Drug Distributors List
Table 57. Montelukast Drug Customer List
Table 58. Global Montelukast Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Montelukast Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Montelukast Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Montelukast Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Montelukast Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Montelukast Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Montelukast Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Montelukast Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Montelukast Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Montelukast Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Montelukast Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Montelukast Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Montelukast Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Montelukast Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck & Co. Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck & Co. Montelukast Drug Product Portfolios and Specifications
Table 74. Merck & Co. Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck & Co. Main Business
Table 76. Merck & Co. Latest Developments
Table 77. Teva Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Montelukast Drug Product Portfolios and Specifications
Table 79. Teva Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Mylan Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Mylan Montelukast Drug Product Portfolios and Specifications
Table 84. Mylan Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Mylan Main Business
Table 86. Mylan Latest Developments
Table 87. Glenmark Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Glenmark Pharmaceuticals Montelukast Drug Product Portfolios and Specifications
Table 89. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Glenmark Pharmaceuticals Main Business
Table 91. Glenmark Pharmaceuticals Latest Developments
Table 92. Hikma Group Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Hikma Group Montelukast Drug Product Portfolios and Specifications
Table 94. Hikma Group Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Hikma Group Main Business
Table 96. Hikma Group Latest Developments
Table 97. Sandoz Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Sandoz Montelukast Drug Product Portfolios and Specifications
Table 99. Sandoz Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Sandoz Main Business
Table 101. Sandoz Latest Developments
Table 102. Torrent Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Torrent Pharmaceuticals Montelukast Drug Product Portfolios and Specifications
Table 104. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Torrent Pharmaceuticals Main Business
Table 106. Torrent Pharmaceuticals Latest Developments
Table 107. Lannett Company Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Lannett Company Montelukast Drug Product Portfolios and Specifications
Table 109. Lannett Company Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Lannett Company Main Business
Table 111. Lannett Company Latest Developments
Table 112. Apotex Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Apotex Montelukast Drug Product Portfolios and Specifications
Table 114. Apotex Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Apotex Main Business
Table 116. Apotex Latest Developments
Table 117. Dr. Reddys Laboratories Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Dr. Reddys Laboratories Montelukast Drug Product Portfolios and Specifications
Table 119. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Dr. Reddys Laboratories Main Business
Table 121. Dr. Reddys Laboratories Latest Developments
Table 122. Aurobindo Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurobindo Pharma Montelukast Drug Product Portfolios and Specifications
Table 124. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Aurobindo Pharma Main Business
Table 126. Aurobindo Pharma Latest Developments
Table 127. Accord Healthcare Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Accord Healthcare Montelukast Drug Product Portfolios and Specifications
Table 129. Accord Healthcare Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Accord Healthcare Main Business
Table 131. Accord Healthcare Latest Developments
Table 132. Hetero Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Hetero Montelukast Drug Product Portfolios and Specifications
Table 134. Hetero Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Hetero Main Business
Table 136. Hetero Latest Developments
Table 137. Unimark Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Unimark Montelukast Drug Product Portfolios and Specifications
Table 139. Unimark Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Unimark Main Business
Table 141. Unimark Latest Developments
Table 142. Ajanta Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Ajanta Pharma Montelukast Drug Product Portfolios and Specifications
Table 144. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Ajanta Pharma Main Business
Table 146. Ajanta Pharma Latest Developments
Table 147. MACLEODS Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. MACLEODS Montelukast Drug Product Portfolios and Specifications
Table 149. MACLEODS Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. MACLEODS Main Business
Table 151. MACLEODS Latest Developments
Table 152. Jubilant Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Jubilant Pharma Montelukast Drug Product Portfolios and Specifications
Table 154. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Jubilant Pharma Main Business
Table 156. Jubilant Pharma Latest Developments
Table 157. Unichem Laboratories Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Unichem Laboratories Montelukast Drug Product Portfolios and Specifications
Table 159. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Unichem Laboratories Main Business
Table 161. Unichem Laboratories Latest Developments
Table 162. Amneal Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Amneal Pharmaceuticals Montelukast Drug Product Portfolios and Specifications
Table 164. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 165. Amneal Pharmaceuticals Main Business
Table 166. Amneal Pharmaceuticals Latest Developments
Table 167. Shanghai Anbison Lab Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. Shanghai Anbison Lab Montelukast Drug Product Portfolios and Specifications
Table 169. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 170. Shanghai Anbison Lab Main Business
Table 171. Shanghai Anbison Lab Latest Developments
Table 172. Perrigo Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 173. Perrigo Montelukast Drug Product Portfolios and Specifications
Table 174. Perrigo Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 175. Perrigo Main Business
Table 176. Perrigo Latest Developments
Table 177. Cipla Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 178. Cipla Montelukast Drug Product Portfolios and Specifications
Table 179. Cipla Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 180. Cipla Main Business
Table 181. Cipla Latest Developments
Table 182. CSPC Ouyi Pharmaceutical Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 183. CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolios and Specifications
Table 184. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 185. CSPC Ouyi Pharmaceutical Main Business
Table 186. CSPC Ouyi Pharmaceutical Latest Developments


List of Figures
Figure 1. Picture of Montelukast Drug
Figure 2. Montelukast Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Montelukast Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Montelukast Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Montelukast Drug Sales Market Share by Country/Region (2024)
Figure 10. Montelukast Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Tablets
Figure 12. Product Picture of Oral Granules
Figure 13. Global Montelukast Drug Sales Market Share by Type in 2025
Figure 14. Global Montelukast Drug Revenue Market Share by Type (2020-2025)
Figure 15. Montelukast Drug Consumed in Hospital
Figure 16. Global Montelukast Drug Market: Hospital (2020-2025) & (K Units)
Figure 17. Montelukast Drug Consumed in Drug Store
Figure 18. Global Montelukast Drug Market: Drug Store (2020-2025) & (K Units)
Figure 19. Montelukast Drug Consumed in Others
Figure 20. Global Montelukast Drug Market: Others (2020-2025) & (K Units)
Figure 21. Global Montelukast Drug Sale Market Share by Application (2024)
Figure 22. Global Montelukast Drug Revenue Market Share by Application in 2025
Figure 23. Montelukast Drug Sales by Company in 2025 (K Units)
Figure 24. Global Montelukast Drug Sales Market Share by Company in 2025
Figure 25. Montelukast Drug Revenue by Company in 2025 ($ millions)
Figure 26. Global Montelukast Drug Revenue Market Share by Company in 2025
Figure 27. Global Montelukast Drug Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Montelukast Drug Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Montelukast Drug Sales 2020-2025 (K Units)
Figure 30. Americas Montelukast Drug Revenue 2020-2025 ($ millions)
Figure 31. APAC Montelukast Drug Sales 2020-2025 (K Units)
Figure 32. APAC Montelukast Drug Revenue 2020-2025 ($ millions)
Figure 33. Europe Montelukast Drug Sales 2020-2025 (K Units)
Figure 34. Europe Montelukast Drug Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Montelukast Drug Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Montelukast Drug Revenue 2020-2025 ($ millions)
Figure 37. Americas Montelukast Drug Sales Market Share by Country in 2025
Figure 38. Americas Montelukast Drug Revenue Market Share by Country (2020-2025)
Figure 39. Americas Montelukast Drug Sales Market Share by Type (2020-2025)
Figure 40. Americas Montelukast Drug Sales Market Share by Application (2020-2025)
Figure 41. United States Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Montelukast Drug Sales Market Share by Region in 2025
Figure 46. APAC Montelukast Drug Revenue Market Share by Region (2020-2025)
Figure 47. APAC Montelukast Drug Sales Market Share by Type (2020-2025)
Figure 48. APAC Montelukast Drug Sales Market Share by Application (2020-2025)
Figure 49. China Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. India Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Montelukast Drug Sales Market Share by Country in 2025
Figure 57. Europe Montelukast Drug Revenue Market Share by Country (2020-2025)
Figure 58. Europe Montelukast Drug Sales Market Share by Type (2020-2025)
Figure 59. Europe Montelukast Drug Sales Market Share by Application (2020-2025)
Figure 60. Germany Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. France Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Montelukast Drug Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Montelukast Drug Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Montelukast Drug Sales Market Share by Application (2020-2025)
Figure 68. Egypt Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Montelukast Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Montelukast Drug in 2025
Figure 74. Manufacturing Process Analysis of Montelukast Drug
Figure 75. Industry Chain Structure of Montelukast Drug
Figure 76. Channels of Distribution
Figure 77. Global Montelukast Drug Sales Market Forecast by Region (2026-2031)
Figure 78. Global Montelukast Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Montelukast Drug Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Montelukast Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Montelukast Drug Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Montelukast Drug Revenue Market Share Forecast by Application (2026-2031)